GSK-Novartis transaction approved in Canada based on commitments in EU and US
February 27th, 2015
A proposed transaction between two multinational pharmaceutical and consumer healthcare product companies, GlaxoSmithKline (GSK) and Novartis was recently given the go-ahead by the Competition Bureau. The proposed transaction was announced ... [more] Full article
